- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Angiotensin-Derived Nootropic · Educational Resource
Understanding Dihexa and Synaptogenesis Research
Angiotensin IV Analog
(Small Molecule Compound)
Investigational Application
Synaptogenesis, cognitive research
Administration Protocol
Oral, per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Angiotensin-Derived Nootropic · Educational Resource
Understanding Dihexa and Synaptogenesis Research
01 — Overview
What is Dihexa?
Dihexa is a small molecule compound derived from angiotensin IV, originally researched in the context of Alzheimer's disease and cognitive decline studies.
As a very early-stage investigational compound, Dihexa has not received regulatory approval for therapeutic use in the Philippines or elsewhere, and existing literature is largely limited to preclinical, animal-model research.
Within research literature, Dihexa is most frequently studied for its relationship to synaptogenesis (the formation of new synapses) and memory-related pathways, areas summarized further below.
02 — How it works
How It Works: HGF/c-Met Pathway Activation and Synaptogenesis
As an angiotensin IV analog, Dihexa is studied for its ability to activate the hepatocyte growth factor (HGF) and c-Met receptor pathway, a signaling system researchers associate with synaptic growth and neural connectivity.
Literature describes this synaptogenic mechanism as significantly more potent in preclinical models compared to earlier compounds studied in the same research lineage, such as BDNF-based approaches.
Administration in Research
In preclinical literature, Dihexa is evaluated primarily via oral administration within controlled research protocols. As a very early-stage investigational compound, it has not received regulatory approval for therapeutic use, and research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Preclinical literature evaluates Dihexa across several key physiological parameters to map its biological interactions:
HGF/c-Met Signaling Pathways
Research literature evaluates how Dihexa is studied for its relationship to hepatocyte growth factor (HGF) and its c-Met receptor, pathways associated with synaptic growth.
Synaptogenesis Studies
Preclinical studies observe new synapse formation markers following Dihexa exposure in animal research models.
Memory Formation Parameters
Investigational literature examines spatial memory and learning parameters in preclinical research models.
Neurodegeneration Research
Studies explore Dihexa's studied relationship to neurodegenerative disease models, an area of its original research origin.
Blood-Brain Barrier Penetration Studies
Some literature investigates Dihexa's studied ability to cross the blood-brain barrier, a property relevant to its research applications.
Pharmacokinetic Profiling
Studies characterize the oral bioavailability profile of Dihexa in preclinical research.
04 — FAQ
Frequently Asked Questions
05 — References
References and Academic Literature
McCoy, A.T., et al. (2013). Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents. Journal of Pharmacology and Experimental Therapeutics.
Benoist, C.C., et al. (2011). The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System. Journal of Pharmacology and Experimental Therapeutics.
Wright, J.W., & Harding, J.W. (2015). The Brain Renin-Angiotensin System and Cognitive Function. Cellular and Molecular Neurobiology.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups
